{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T15:01:34Z","timestamp":1794841294167,"version":"4.9.1"},"publisher-location":"New York, NY","reference-count":25,"publisher":"Springer US","isbn-type":[{"value":"9781071650363","type":"print"},{"value":"9781071650370","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5037-0_3","type":"book-chapter","created":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T22:21:24Z","timestamp":1778451684000},"page":"33-46","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Generation of Bispecific Antibodies Using FAST-Ig\u2122"],"prefix":"10.1007","author":[{"given":"Chiew Ying","family":"Yeo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"issue":"8","key":"3_CR1","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41573-019-0028-1","volume":"18","author":"AF Labrijn","year":"2019","unstructured":"Labrijn AF, Janmaat ML, Reichert JM, Parren PW (2019) Bispecific antibodies: a mechanistic review of the pipeline. Nat Rev Drug Discov 18(8):585\u2013608","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"3_CR2","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41573-024-00896-6","volume":"23","author":"C Klein","year":"2024","unstructured":"Klein C, Brinkmann U, Reichert JM, Kontermann RE (2024) The present and future of bispecific antibodies for cancer therapy. Nat Rev Drug Discov 23(4):301\u2013319","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"3_CR3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1080\/19420862.2016.1268307","volume":"9","author":"U Brinkmann","year":"2017","unstructured":"Brinkmann U, Kontermann RE (2017) The making of bispecific antibodies. MAbs 9(2):182\u2013212","journal-title":"MAbs"},{"issue":"5","key":"3_CR4","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s40259-018-0299-9","volume":"32","author":"B Husain","year":"2018","unstructured":"Husain B, Ellerman D (2018) Expanding the boundaries of biotherapeutics with bispecific antibodies. BioDrugs 32(5):441\u2013464","journal-title":"BioDrugs"},{"issue":"1","key":"3_CR5","doi-asserted-by":"publisher","first-page":"2362789","DOI":"10.1080\/19420862.2024.2362789","volume":"16","author":"W-TK Tsai","year":"2024","unstructured":"Tsai W-TK, Li Y, Yin Z, Tran P, Phung Q, Zhou Z, Peng K, Qin D, Tam S, Spiess C (2024) Nonclinical immunogenicity risk assessment for knobs-into-holes bispecific IgG1 antibodies. Mabs 16(1):2362789","journal-title":"Mabs"},{"issue":"5","key":"3_CR6","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1080\/19420862.2019.1612699","volume":"11","author":"N Bivi","year":"2019","unstructured":"Bivi N, Moore T, Rodgers G, Denning H, Shockley T, Swearingen CA, Gelfanova V, Calderon B, Peterson DA, Hodsdon ME (2019) Investigation of pre-existing reactivity to biotherapeutics can uncover potential immunogenic epitopes and predict immunogenicity risk. MAbs 11(5):861\u2013869","journal-title":"MAbs"},{"key":"3_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.pep.2018.11.011","volume":"155","author":"Y Li","year":"2019","unstructured":"Li Y (2019) A brief introduction of IgG-like bispecific antibody purification: methods for removing product-related impurities. Protein Expr Purif 155:112\u2013119","journal-title":"Protein Expr Purif"},{"issue":"7","key":"3_CR8","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/protein\/9.7.617","volume":"9","author":"JB Ridgway","year":"1996","unstructured":"Ridgway JB, Presta LG, Carter P (1996) \u2018Knobs-into-holes\u2019 engineering of antibody CH3 domains for heavy chain heterodimerization. Protein Eng. Des Sel 9(7):617\u2013621","journal-title":"Protein Eng. Des Sel"},{"issue":"7","key":"3_CR9","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nbt0798-677","volume":"16","author":"AM Merchant","year":"1998","unstructured":"Merchant AM, Zhu Z, Yuan JQ, Goddard A, Adams CW, Presta LG, Carter P (1998) An efficient route to human bispecific IgG. Nat Biotechnol 16(7):677\u2013681","journal-title":"Nat Biotechnol"},{"key":"3_CR10","unstructured":"Igawa T, Tsunoda H (2006) Methods for producing polypeptides by regulating polypeptide association. WO2006106905, 12 October 2006"},{"issue":"25","key":"3_CR11","doi-asserted-by":"publisher","first-page":"19637","DOI":"10.1074\/jbc.M110.117382","volume":"285","author":"K Gunasekaran","year":"2010","unstructured":"Gunasekaran K, Pentony M, Shen M, Garrett L, Forte C, Woodward A, Ng SB, Born T, Retter M, Manchulenko K (2010) Enhancing antibody Fc heterodimer formation through electrostatic steering effects: applications to bispecific molecules and monovalent IgG. JBiol Chem 285(25):19637\u201319646","journal-title":"JBiol Chem"},{"issue":"2","key":"3_CR12","doi-asserted-by":"publisher","first-page":"e57479","DOI":"10.1371\/journal.pone.0057479","volume":"8","author":"Z Sampei","year":"2013","unstructured":"Sampei Z, Igawa T, Soeda T, Okuyama-Nishida Y, Moriyama C, Wakabayashi T, Tanaka E, Muto A, Kojima T, Kitazawa T (2013) Identification and multidimensional optimization of an asymmetric bispecific IgG antibody mimicking the function of factor VIII cofactor activity. PLoS One 8(2):e57479","journal-title":"PLoS One"},{"issue":"27","key":"3_CR13","doi-asserted-by":"publisher","first-page":"11187","DOI":"10.1073\/pnas.1019002108","volume":"108","author":"W Schaefer","year":"2011","unstructured":"Schaefer W, Regula JT, B\u00e4hner M, Schanzer J, Croasdale R, D\u00fcrr H, Gassner C, Georges G, Kettenberger H, Imhof-Jung S (2011) Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies. Proc Natl Acad Sci 108(27):11187\u201311192","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"3_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nbt.2797","volume":"32","author":"SM Lewis","year":"2014","unstructured":"Lewis SM, Wu X, Pustilnik A, Sereno A, Huang F, Rick HL, Guntas G, Leaver-Fay A, Smith EM, Ho C (2014) Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface. Nat Biotechnol 32(2):191\u2013198","journal-title":"Nat Biotechnol"},{"issue":"2","key":"3_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/19420862.2016.1267089","volume":"9","author":"M Dillon","year":"2017","unstructured":"Dillon M, Yin Y, Zhou J, McCarty L, Ellerman D, Slaga D, Junttila TT, Han G, Sandoval W, Ovacik MA (2017) Efficient production of bispecific IgG of different isotypes and species of origin in single mammalian cells. MAbs 9(2):213\u2013230","journal-title":"MAbs"},{"issue":"12","key":"3_CR16","doi-asserted-by":"publisher","first-page":"7535","DOI":"10.1074\/jbc.M114.620260","volume":"290","author":"Z Liu","year":"2015","unstructured":"Liu Z, Leng EC, Gunasekaran K, Pentony M, Shen M, Howard M, Stoops J, Manchulenko K, Razinkov V, Liu H (2015) A novel antibody engineering strategy for making monovalent bispecific heterodimeric IgG antibodies by electrostatic steering mechanism. J Biol Chem 290(12):7535\u20137562","journal-title":"J Biol Chem"},{"issue":"2","key":"3_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1080\/19420862.2015.1007816","volume":"7","author":"Y Mazor","year":"2015","unstructured":"Mazor Y, Oganesyan V, Yang C, Hansen A, Wang J, Liu H, Sachsenmeier K, Carlson M, Gadre DV, Borrok MJ (2015) Improving target cell specificity using a novel monovalent bispecific IgG design. MAbs 7(2):377\u2013389","journal-title":"MAbs"},{"key":"3_CR18","doi-asserted-by":"publisher","first-page":"1352014","DOI":"10.3389\/fbioe.2024.1352014","volume":"12","author":"AV Madsen","year":"2024","unstructured":"Madsen AV, Pedersen LE, Kristensen P, Goletz S (2024) Design and engineering of bispecific antibodies: insights and practical considerations. Front Bioeng Biotechnol 12:1352014","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"3_CR19","doi-asserted-by":"publisher","first-page":"2222441","DOI":"10.1080\/19420862.2023.2222441","volume":"15","author":"H Koga","year":"2023","unstructured":"Koga H, Yamano T, Betancur J, Nagatomo S, Ikeda Y, Yamaguchi K, Nabuchi Y, Sato K, Teranishi-Ikawa Y, Sato M (2023) Efficient production of bispecific antibody by FAST-IgTM and its application to NXT007 for the treatment of hemophilia A. MAbs 15(1):2222441","journal-title":"MAbs"},{"issue":"8","key":"3_CR20","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1080\/19420862.2016.1232217","volume":"8","author":"Y Yin","year":"2016","unstructured":"Yin Y, Han G, Zhou J, Dillon M, McCarty L, Gavino L, Ellerman D, Spiess C, Sandoval W, Carter PJ (2016) Precise quantification of mixtures of bispecific IgG produced in single host cells by liquid chromatography-Orbitrap high-resolution mass spectrometry. MAbs 8(8):1467\u20131476","journal-title":"MAbs"},{"key":"3_CR21","unstructured":"Kuramochi T, Kawazoe M, Hironiwa N, Igawa\u00a0T (2013) Antigen-binding molecule having regulated conjugation between heavy-chain and light-chain. WO2013065708, 10 May 2013"},{"key":"3_CR22","unstructured":"Teranishi Y, Kato K, Koga H, Igawa T, Yamaguchi K, Soeda T (2019) Multispecific antigen-binding molecules having blood coagulation factor VIII (FVIII) cofactor function-substituting activity and pharmaceutical formulations containing such a molecule as an active ingredient. WO2019065795, 2019"},{"issue":"1","key":"3_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/antib13010003","volume":"13","author":"H Koga","year":"2024","unstructured":"Koga H, Kuroi H, Hirano R, Hirayama H, Nabuchi Y, Kuramochi T (2024) Rapid generation of murine bispecific antibodies using FAST-IgTM for preclinical screening of HER2\/CD3 T-cell engagers. Antibodies 13(1):3","journal-title":"Antibodies"},{"issue":"1","key":"3_CR24","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1073\/pnas.63.1.78","volume":"63","author":"GM Edelman","year":"1969","unstructured":"Edelman GM, Cunningham BA, Gall WE, Gottlieb PD, Rutishauser U, Waxdal MJ (1969) The covalent structure of an entire \u03b3G immunoglobulin molecule. Proc Natl Acad Sci 63(1):78\u201385","journal-title":"Proc Natl Acad Sci"},{"key":"3_CR25","volume-title":"Sequences of proteins of immunological interest","author":"EA Kabat","year":"1991","unstructured":"Kabat EA, Te Wu T, Perry HM, Gottesman KS, Foeller C (1991) Sequences of proteins of immunological interest, 5th edn. US Department of Health and Human Services, Public Health Service, National Institutes of Health, Bethesda, MD","edition":"5th edn"}],"container-title":["Methods in Molecular Biology","Bispecific Antibodies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5037-0_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T22:21:25Z","timestamp":1778451685000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5037-0_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071650363","9781071650370"],"references-count":25,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5037-0_3","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-0716-5037-0","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"1 May 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}